HSV-2 gE Envelope Protein Antibody (6F10): sc-56990

HSV-2 gE Envelope Protein Antibody (6F10) is a mouse monoclonal IgG2a antibody that detects HSV-2 gE Envelope Protein of Herpes Simplex Virus 2 by immunofluorescence (IF). HSV-2 gE Envelope Protein (6F10) antibody recognizes a glycoprotein crucial for viral lifecycle, particularly in mediating virus entry into host cells. HSV-2 gE Envelope Protein monoclonal antibody (6F10) helps researchers study specific receptors on host cell surfaces that enable viral envelope fusion with cell membranes. Anti-HSV-2 gE Envelope Protein antibody (6F10) aids in understanding receptor interactions during infection processes, making this glycoprotein essential for viral entry and establishment. HSV-2 gE Envelope Protein (6F10) monoclonal antibody serves as a valuable research tool for studying infection mechanisms and developing potential antiviral therapies.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

HSV-2 gE Envelope Protein Antibody (6F10) References:

1. HSV-2 ICP34.5 protein modulates herpes simplex virus glycoprotein processing.  |  Chatterjee, S., et al. 2009. Arch Virol. 154: 661-3. PMID: 19267180
2. Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.  |  Bröker, M., et al. 1990. Med Microbiol Immunol. 179: 145-59. PMID: 2169577
3. HSV-2 glycoprotein J promotes viral protein expression and virus spread.  |  Liu, Y., et al. 2018. Virology. 525: 83-95. PMID: 30248525
4. pUL21 regulation of pUs3 kinase activity influences the nature of nuclear envelope deformation by the HSV-2 nuclear egress complex.  |  Muradov, JH., et al. 2021. PLoS Pathog. 17: e1009679. PMID: 34424922

The preferred HSV-2 gE Envelope Protein antibody is HSV-2 gE Envelope Protein Antibody (101): sc-52861.